ARNA Financial Facts

Total interest and other expense, net: 172K
Collaborative agreements: 3.21M
See Full Income Statement

Deferred revenues, less current portion: 92.65M
Total liabilities and stockholders' equity: 329.12M
See Full Balance Sheet

Arena Pharmaceuticals, Inc. (ARNA) Earnings

  |   Expand Research on ARNA
Next EPS Date 11/3/15 *Est. EPS Growth Rate -466.7% *Last Qtr.
Average EPS % Beat Rate +20.8% Revenue Growth Rate -28.3% *Last Qtr.
Average % Move 1-Wk after EPS -3.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/10 Q310 -$0.31-$0.23 -$0.08N/AN/A N/A Details
3/11/11 Q410 -$0.23-$0.21 -$0.02$4.01M$4.81M N/A Details
5/10/11 Q111 -$0.35-$0.21 -$0.14$3.92M$3.29M N/A Details
8/9/11 Q211 -$0.16-$0.16 $0.00$3.26M$3.35M N/A Details
3/14/12 Q411 -$0.16-$0.15 -$0.01$2.08M$3.49M N/A Details
8/5/15 Q215 -$0.11-$0.14 +$0.03$9.18M$10.95M N/A Details
5/11/15 Q115 -$0.10-$0.14 +$0.04$12.3M$10.56M N/A Details
11/9/11 Q311 -$0.16-$0.14 -$0.02$3.46M$3.37M N/A Details